Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Braintree, A part of SEBELA Pharmaceuticals
FDA Inspection
•Braintree, A part of SEBELA Pharmaceuticals•January 21, 2011

Braintree, A part of SEBELA Pharmaceuticals – FDA Inspection, Jan 21, 2011

Record Details

This FDA Inspection record concerns Braintree, A part of SEBELA Pharmaceuticals, with an inspection on January 21, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Braintree, A part of SEBELA Pharmaceuticals
Inspection Date
January 21, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 2980d372-45f6-4f29-bbd3-a2e16a160b75

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
707123
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

7
  1. 21 CFR 211.84(d)(2)Component written specification
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  4. 21 CFR 211.84(c)(4)Top/Middle/Bottom container sampling
  5. 21 CFR 211.22(c)Approve or reject procedures or specs
  6. 21 CFR 211.100(a)Absence of Written Procedures
  7. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Braintree, A part of SEBELA Pharmaceuticals

6
DateClassificationOfficeProject area
March 7, 2025NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 28, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 13, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 14, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 22, 2010OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Braintree, A part of SEBELA Pharmaceuticals
  • FDA Inspection 1261728 - 2025-03-07
  • FDA Inspection 1042622 - 2018-02-28
  • FDA Inspection 858979 - 2013-12-13
  • FDA Inspection 814842 - 2013-01-14
  • FDA Inspection 639857 - 2010-01-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Braintree, A part of SEBELA Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.